HTL Biotechnology inaugurates a new production line dedicated to sterile Hyaluronic Acid
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.
It was in 1934 that German chemist Karl Meyer and his British student John Palmer first isolated Hyaluronic Acid from the human body.
This year marks the 90th anniversary of the discovery of this molecule, which is used today in a large number of leading therapeutic areas and whose chemical specificities still conceal many discoveries for years to come.
To mark the occasion, HTL Biotechnology is committed to celebrating this anniversary throughout 2024. On the agenda : events and presentations on Hyaluronic Acid will guide you into the world of this fascinating molecule.
For the more curious among you, stay tuned by subscribing to the hashtag #90YearsofHAwithHTL ! 2024 is set to be a year full of learning and discovery !
On October 28, 2025, HTL Biotechnology hosted its first-ever webinar, “Shaping the Future of Aesthetic Medicine with Premium Biopolymers,” a key initiative to strengthen our presence in Asia and promote the “Feel the Difference with HTL Inside” positioning among major players in aesthetic medicine.
This October, HTL Biotechnology turned pink to support breast cancer prevention.
HTL Biotechnology is the winner of the Responsible Care West Atlantic Trophy in the ‘Energy – Climate’ category for its project to reduce carbon emissions from distillation systems.